Candriam Equities L Oncology Impact, V - Capitalisation/ LU2425425506 /
| NAV06/06/2024 | Diferencia+4.4501 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 1,843.8000GBP | +0.24% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | - | - | 6.68 | -1.24 | -1.68 | 3.85 | 4.18 | 1.33 | -0.64 | 3.81 | 2.58 | -4.38 | - |
| 2023 | -0.16 | -2.24 | -0.70 | 1.18 | -1.15 | -2.41 | -0.29 | -0.49 | -1.60 | -5.78 | 4.71 | 5.03 | -4.28% |
| 2024 | 1.50 | 4.87 | 1.65 | -2.50 | 0.81 | 2.19 | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 10.94% | 10.92% | 11.43% | -% | -% |
| Índice de Sharpe | 1.62 | 2.13 | 0.12 | - | - |
| El mes mejor | +5.03% | +5.03% | +5.03% | +6.68% | - |
| El mes peor | -2.50% | -2.50% | -5.78% | -5.78% | - |
| Pérdida máxima | -4.94% | -4.94% | -12.77% | - | - |
| Rendimiento superior | - | - | - | - | - |
Todas las cotizaciones en GBP
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,402.3501 | +8.18% | +4.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,567.2300 | +8.32% | +5.38% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.7400 | +4.62% | -5.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,235.0200 | +4.75% | +15.35% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.9800 | +7.83% | +3.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.2300 | +4.97% | +13.24% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2600 | +6.82% | +1.10% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3900 | +7.73% | +3.67% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,691.0000 | +2.80% | +0.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.1100 | +4.63% | +14.96% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,113.1299 | +5.61% | -3.17% | |
| Candriam Equities L Oncology Imp... | reinvestment | 259.9500 | +5.87% | +16.14% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.1800 | +4.19% | -6.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.9900 | +7.72% | +3.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.0700 | +5.49% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,843.8000 | +5.09% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,875.2300 | +7.38% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.6200 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.5400 | +6.37% | +0.73% |
Performance
| Año hasta la fecha | +8.68% | ||
|---|---|---|---|
| 6 Meses | +12.66% | ||
| Promedio móvil | +5.09% | ||
| 3 Años | - | ||
| 5 Años | - | ||
| 10 Años | - | ||
| Desde el principio | +23.54% | ||
| Año | |||
| 2023 | -4.28% | ||
